These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 826183)
41. Synthesis and conformational studies by 1H- and 13C-NMR spectroscopy of a novel, sterically constrained analogue of thyrotropin-releasing hormone. Mapelli C; Van Halbeek H; Stammer CH Biopolymers; 1990 Feb; 29(2):407-22. PubMed ID: 2158826 [TBL] [Abstract][Full Text] [Related]
42. Conformational energy studies on N-methylated analogs of thyrotropin releasing hormone, enkephalin, and luteinizing hormone-releasing hormone. Manavalan P; Momany FA Biopolymers; 1980 Nov; 19(11):1943-73. PubMed ID: 6776998 [No Abstract] [Full Text] [Related]
44. Concentrations of thyrotropin-releasing hormone (TRH) and deamido-TRH, and TRH deamidase activity in brain. Emerson CH; Vogel W; Currie BL Endocrinology; 1980 Aug; 107(2):443-9. PubMed ID: 6771121 [No Abstract] [Full Text] [Related]
45. TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects. Angyal R; Strbák V; Alexandrová M; Kruszyński M Endocrinol Exp; 1985 Dec; 19(4):213-9. PubMed ID: 3002750 [TBL] [Abstract][Full Text] [Related]
46. The effect of TRH and its analogues, (Pro-NH-NH2)3TRH and (2-Picolyl)1-TRH on TSH level in rat serum. Ryzewska M; Targońska I; Staff-Zielińska E; Nauman J Mater Med Pol; 1980; 12(1-2):136-9. PubMed ID: 6799705 [No Abstract] [Full Text] [Related]
47. Thyrotropin releasing hormone and its analogues I. New syntheses and biological properties of TRH (Pro-NH-NH2)3-TRH and (2-Picolyl)-TRH. Bobrowska J; Leroux P; Maliński E; Przybylski J; Szafranek J; Tonon MC; Vaudry H; Kupryszewski G Mater Med Pol; 1980; 12(1-2):129-35. PubMed ID: 6799704 [No Abstract] [Full Text] [Related]
48. Serum inactivation of the immunological and biological activity of thyrotropin releasing hormone (TRH). Bassiri R; Utiger RD Endocrinology; 1972 Sep; 91(3):657-64. PubMed ID: 4625231 [No Abstract] [Full Text] [Related]
49. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes. Rahmani NH; Gulati A; Bhargava HN Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623 [TBL] [Abstract][Full Text] [Related]
50. Hydrocortisone increases the number of receptors for thyrotropin-releasing hormone on pituitary cells in culture. Tashjian AH; Osborne R; Maina D; Knaian A Biochem Biophys Res Commun; 1977 Nov; 79(1):333-40. PubMed ID: 200244 [No Abstract] [Full Text] [Related]
51. On the conformation of thyrotropin releasing hormone. Sievertsson H; Castensson S; Bowers CY FEBS Lett; 1974 Jun; 42(3):340-2. PubMed ID: 4212210 [No Abstract] [Full Text] [Related]
53. Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy. Kato Z; Okuda M; Okumura Y; Arai T; Teramoto T; Nishimura M; Kaneko H; Kondo N J Child Neurol; 2009 Aug; 24(8):1010-2. PubMed ID: 19666885 [TBL] [Abstract][Full Text] [Related]
54. A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology. Hichens M Drug Metab Rev; 1983; 14(1):77-98. PubMed ID: 6301791 [No Abstract] [Full Text] [Related]
55. Pharmacological studies of thyrotropin-releasing hormone (TRH) receptors from Xenopus laevis: is xTRHR3 a TRH receptor? Lu X; Bidaud I; Ladram A; Gershengorn MC Endocrinology; 2003 May; 144(5):1842-6. PubMed ID: 12697690 [TBL] [Abstract][Full Text] [Related]
56. Suppression of prolactin and thyrotropin secretion in the rat by antiserum to thyrotropin-releasing hormone. Koch Y; Goldhaber G; Fireman I; Zor U; Shani J; Tal E Endocrinology; 1977 May; 100(5):1476-8. PubMed ID: 403069 [TBL] [Abstract][Full Text] [Related]
57. Distribution of thyrotropin-releasing hormone binding sites: autoradiographic study in infant and adult human hippocampal formation. Eymin C; Champier J; Duvernoy HM; Martin D; Kopp N; Jordan D Brain Res; 1993 Mar; 605(1):139-46. PubMed ID: 8467383 [TBL] [Abstract][Full Text] [Related]
58. Conformational properties of 2,3-methanopyroglutamic acid in peptides: NMR and x-ray diffraction studies. Mapelli C; Elrod LF; Switzer FL; Stammer CH; Holt EM Biopolymers; 1989 Jan; 28(1):123-8. PubMed ID: 2497811 [TBL] [Abstract][Full Text] [Related]
59. Thyrotrophin and prolactin response to beta-(pyrazolyl-1)-alanine-2-TRH in normal males. Garcia-Centenera JA; Vilchez-Lafuente JM; Hervas F; Alba JP; Pozuelo V; Coy DH; Schally AV Horm Metab Res; 1981 Feb; 13(2):107-9. PubMed ID: 6785179 [TBL] [Abstract][Full Text] [Related]